Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study

Transplant International

Volumn 32, Issue 4, 2019, Pages 399-409

  Tuyls, Sebastiaan ^a   Verleden, Stijn E ^b   Wuyts, Wim A ^a,b   Yserbyt, Jonas ^a,b   Vos, Robin ^a,b   Verleden, Geert M ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

corticosteroids; functional testing; lung transplantation; outcome

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CORTICOSTEROID; METHYLPREDNISOLONE; NINTEDANIB; PIRFENIDONE; PREDNISONE;

ALLOGRAFT; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; FIBROSING ALVEOLITIS; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; PINCH STRENGTH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIX MINUTE WALK TEST; SURVIVAL RATE; TREATMENT DURATION; ADULT; AGED; BODY MASS; MIDDLE AGED; MORTALITY;

ADRENAL CORTEX HORMONES; ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 85058968825     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.13382     Document Type: Article

References (51)

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788.
2. King TE Jr, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025.
3. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19: 275.
4. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199.
5. Richeldi L, du Bois R, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071.
6. King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083.
7. Richeldi L, Cottin V, du Bois RM, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS trials. Respir Med 2016; 113: 74.
8. Fleetwood K, McCool R, Glanville J, et al. Systematic review and network meta-analysis of idiopathic pulmonary fibrosis treatments. J Manag Care Spec Pharm 2017; 23: S5.
9. Keating D, Levvey B, Kotsimbos T, et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. Transplant Proc 2009; 41: 289.
10. Thabut G, Mal H, Castier Y, et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003; 126: 469.
11. Alalawi R, Whelan T, Bajwa RS, Hodges TN. Lung transplantation and interstitial lung disease. Curr Opin Pulm Med 2005; 11: 461.
12. Mason DP, Brizzio ME, Alster JM, et al. Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 2007; 84: 1121.
13. Flaherty KR, Toews GB, Lynch JP III, et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001; 110: 278.
14. Puri V, Patterson A, Meyers BF. Single versus bilateral lung transplantation: do guidelines exist? Thorac Surg Clin 2015; 25: 47.
15. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063.
16. ten Klooster L, Nossent GD, Kwakkel-Van Erp JM, et al. Ten-year survival in patients with idiopathic pulmonary fibrosis after lung transplantation. Lung 2015; 193: 919.
17. Arango Tomás EA, Algar Algar FJ, Cerezo Madueño F, Salvatierra Velázquez A. Evolution and risk factors for early mortality after lung transplantation for idiopathic pulmonary fibrosis: an experience of 20 years. Transplant Proc 2015; 47: 2656.
18. Nagai S, Kitaichi M, Hamada K, et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 209.
19. Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012; 366: 1968.
20. Richeldi L, Davies HR, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003; (3): CD002880.
21. Lima O, Cooper JD, Peters WJ, et al. Effects of methylprednisolone and azathioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg 1981; 82: 211.
22. Patterson GA, Cooper JD. Status of lung transplantation. Surg Clin North Am 1988; 68: 545.
23. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 1998; 17: 703.
24. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update–a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745.
25. Goldberg M, Lima O, Morgan E, et al. A comparison between cyclosporin A and methylprednisolone plus azathioprine on bronchial healing following canine lung autotransplantation. J Thorac Cardiovasc Surg 1983; 85: 821.
26. Schäfers HJ, Wagner TO, Demertzis S, et al. Preoperative corticosteroids. A contraindication to lung transplantation?. Chest 1992; 102: 1522.
27. Park SJ, Nguyen DQ, Savik K, et al. Pretransplant corticosteroid use and outcome in lung transplantation. J Heart Lung Transplant 2001; 20: 304.
28. McAnally KJ, Valentine VG, LaPlace SG, et al. Effect of pre-transplantation prednisone on survival after lung transplantation. J Heart Lung Transplant 2006; 25: 67.
29. Magnusson J, Westin J, Andersson LM, et al. Viral respiratory tract infection during the first postoperative year is a risk factor for chronic rejection after lung transplantation. Transplant Direct 2018; 4: 370.
30. Belperio J, Palmer SM, Weigt SS. Host-pathogen interactions and chronic lung allograft dysfunction. Ann Am Thorac Soc 2017; 14: 242.
31. Bowyer S, LaMothe M, Hollister J. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985; 76: 234.
32. Decramer M, Stas KJ. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. Am Rev Respir Dis 1992; 146: 800.
33. Weiner P, Azgard Y, Weiner M. The effect of corticosteroids on inspiratory muscle performance in humans. Chest 1993; 104: 1788.
34. Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G. Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 2002; 20: 497.
35. Zanotti E, Corsico R, Rampulla C, et al. Effect of long-term therapy with oral steroids on respiratory muscle function and ventilatory drive. Monaldi Arch Chest Dis 1993; 48: 16.
36. Picado C, Fiz JA, Montserrat JM, et al. Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. Am Rev Respir Dis 1990; 141: 14.
37. Mak VH, Bugler JR, Spiro SG. Sternomastoid muscle fatigue and twitch maximum relaxation rate in patients with steroid dependent asthma. Thorax 1993; 48: 979.
38. Mills GH, Kyroussis D, Jenkins P, et al. Respiratory muscle strength in Cushing's syndrome. Am J Respir Crit Care Med 1999; 160: 1762.
39. Akkoca O, Mungan D, Karabiyikoglu G, Misirligil Z. Inhaled and systemic corticosteroid therapies: Do they contribute to inspiratory muscle weakness in asthma? Respiration 1999; 66: 332.
40. Perez T, Becquart LA, Stach B, Wallaert B, Tonnel AB. Inspiratory muscle strength and endurance in steroid-dependent asthma. Am J Respir Crit Care Med 1996; 153: 610.
41. Force SD, Kilgo P, Neujahr DC, et al. Bilateral lung transplantation offers better long-term survival, compared with single-lung transplantation, for younger patients with idiopathic pulmonary fibrosis. Ann Thorac Surg 2011; 91: 244.
42. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Factors indicative of longterm survival after lung transplantation: a review of 836 10-year survivors. J Heart Lung Transplant 2010; 29: 240.
43. Meyer KC. Lung transplant for interstitial lung disease. Clin Pulm Med 2000; 7: 178.
44. Lehmann S, Uhlemann M, Leontyev S, et al. Bilateral versus single lung transplant for idiopathic pulmonary fibrosis. Exp Clin Transplant 2014; 12: 443.
45. Whelan TP, Dunitz JM, Kelly RF, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005; 24: 1269.
46. Kistler KD, Nalysnyk L, Rotella P, Esser D. Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature. BMC Pulm Med 2014; 14: 139.
47. Delanote I, Wuyts WA, Yserbyt J, Verbeken EK, Verleden GM, Vos R. Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series. BMC Pulm Med 2016; 16: 156.
48. Balestro E, Solidoro P, Parigi P, Boffini M, Lucianetti A, Rea F. Safety of nintedanib before lung transplant: an Italian case series. Respirol Case Rep 2018; 13: 6.
49. Leuschner G, Stocker F, Veit T, et al. Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy. J Heart Lung Transplant 2017; 17: 31886.
50. Lambers C, Boehm PM, Lee S, et al. Effect of antifibrotics on short-term outcome after bilateral lung transplantation a multi-centre analysis. Eur Respir J 2018; 51: pii: 1800503.
51. Ruttens D, Verleden SE, Vandermeulen E, et al. Body mass index in lung transplant candidates: a contra-indication to transplant or not? Transplant Proc 2014; 46: 1506.